- 专利标题： GENOMIC SAFE HARBORS FOR GENETIC THERAPIES IN HUMAN STEM CELLS AND ENGINEERED NANOPARTICLES TO PROVIDE TARGETED GENETIC THERAPIES
-
申请号： US16619211申请日： 2018-06-05
-
公开(公告)号： US20210171983A1公开(公告)日： 2021-06-10
- 发明人: Jennifer E. Adair , Reza Shahbazi
- 申请人： FRED HUTCHINSON CANCER RESEARCH CENTER
- 申请人地址： US WA Seattle
- 专利权人： FRED HUTCHINSON CANCER RESEARCH CENTER
- 当前专利权人： FRED HUTCHINSON CANCER RESEARCH CENTER
- 当前专利权人地址： US WA Seattle
- 国际申请： PCT/US2018/036154 WO 20180605
- 主分类号： C12N15/90
- IPC分类号： C12N15/90 ; C12N15/113 ; C12N9/22 ; C12N5/078 ; A61K47/69
摘要：
Genomic safe harbors (GSH) for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies are described. The GSH and/or associated nanoparticles can be used to safely and efficiently treat a variety of genetic, infectious, and malignant diseases.
公开/授权文献
信息查询
IPC分类:
